Web NewDrugInformation.com

Mytrex A Drug - Mytrex A The trade name of the product as shown on the labeling. Dosage - OINTMENT; TOPICAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Neomycin Sulfate; Triamcinolone Acetonide Multiple ingredients are in alphabetical order. Strength - EQ 3.5MG BASE/GM;0.1% The potency of the active ingredient(s), Neomycin Sulfate; Triamcinolone Acetonide. May repeat for multiple part products. Applicant - SAVAGE LABS The firm name holding legal responsibility for Mytrex A. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 062609 The FDA assigned number to Mytrex A. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Mytrex A. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - May 23, 1986 The date Mytrex A was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Mytrex A. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - DISCN The group or category of approved drugs Mytrex A is in. Format is RX, OTC, DISCN. Applicant Full Name - Savage Laboratories Inc Div Altana Inc The full name of the firm holding legal responsibility for the new application of Mytrex A. Mytrex A Neosporin G.U. Irrigant Eq 40mg Base/ml;200,000 Units/ml Solution; Irrigation Poly-pred Eq 0.35% Base;10,000 Units/ml;0.5% Suspension/drops; Ophthalmic Neo-delta-cortef Eq 3.5mg Base/gm;0.25% Ointment; Ophthalmic Neo-delta-cortef Eq 3.5mg Base/gm;0.5% Ointment; Ophthalmic Neo-delta-cortef Eq 3.5mg Base/ml;0.25% Suspension/drops; Ophthalmic Neo-hydeltrasol Eq 3.5mg Base/gm;eq 0.25% Phosphate Ointment; Ophthalmic Mytrex A Eq 3.5mg Base/gm;0.1% Cream; Topical Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Cream; Topical Neomycin Sulfate-triamcinolone Acetonide Eq 3.5mg Base/gm;0.1% Cream; Topical Mytrex A Eq 3.5mg Base/gm;0.1% Ointment; Topical NewDrugInformation